198 related articles for article (PubMed ID: 27108649)
1. Knockdown of RHOC by shRNA suppresses invasion and migration of cholangiocellular carcinoma cells via inhibition of MMP2, MMP3, MMP9 and epithelial-mesenchymal transition.
Yang H; Liang J; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Li E
Mol Med Rep; 2016 Jun; 13(6):5255-61. PubMed ID: 27108649
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of microRNA-138 enhances the proliferation, migration and invasion of cholangiocarcinoma cells through the upregulation of RhoC/p-ERK/MMP-2/MMP-9.
Wang Q; Tang H; Yin S; Dong C
Oncol Rep; 2013 May; 29(5):2046-52. PubMed ID: 23446431
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway.
Chen S; Chen X; Xiu YL; Sun KX; Zhao Y
PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027
[TBL] [Abstract][Full Text] [Related]
4. RhoC expression level is correlated with the clinicopathological characteristics of ovarian cancer and the expression levels of ROCK-I, VEGF, and MMP9.
Zhao Y; Zong ZH; Xu HM
Gynecol Oncol; 2010 Mar; 116(3):563-71. PubMed ID: 20022093
[TBL] [Abstract][Full Text] [Related]
5. [Trametenolic acid inhibits migration and invasion of hepatocellular carcinoma HepG2.2.15 cells via RhoC/ROCK1 pathway].
Wan YL; Wang JZ; Yuan Y; Ye WY; Li HL; Zhang XL; Zhang HQ; Li LE
Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):185-196. PubMed ID: 38403351
[TBL] [Abstract][Full Text] [Related]
6. HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC/AKT/MAPK pathway in human cholangiocellular carcinoma.
Yang H; Zhou J; Mi J; Ma K; Fan Y; Ning J; Wang C; Wei X; Zhao H; Li E
Oncol Rep; 2015 Oct; 34(4):1681-91. PubMed ID: 26260613
[TBL] [Abstract][Full Text] [Related]
7. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression.
Ha TY; Hwang S; Moon KM; Won YJ; Song GW; Kim N; Tak E; Ryoo BY; Hong HN
Anticancer Res; 2015 Apr; 35(4):1967-76. PubMed ID: 25862849
[TBL] [Abstract][Full Text] [Related]
9. "Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.
Kaushal N; Durmaz YY; Bao L; Merajver SD; ElSayed ME
Mol Pharm; 2015 Jul; 12(7):2406-17. PubMed ID: 26020100
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of ZNF746 suppresses invasion and epithelial to mesenchymal transition in H460 non-small cell lung cancer cells.
Kim B; Sohn EJ; Jung JH; Shin EA; You OH; Im J; Kim SH
Oncol Rep; 2014 Jan; 31(1):73-8. PubMed ID: 24145959
[TBL] [Abstract][Full Text] [Related]
11. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer.
Iiizumi M; Bandyopadhyay S; Pai SK; Watabe M; Hirota S; Hosobe S; Tsukada T; Miura K; Saito K; Furuta E; Liu W; Xing F; Okuda H; Kobayashi A; Watabe K
Cancer Res; 2008 Sep; 68(18):7613-20. PubMed ID: 18794150
[TBL] [Abstract][Full Text] [Related]
12. Elevated phosphatase of regenerating liver 3 (PRL-3) promotes cytoskeleton reorganization, cell migration and invasion in endometrial stromal cells from endometrioma.
Zhan H; Ma J; Ruan F; Bedaiwy MA; Peng B; Wu R; Lin J
Hum Reprod; 2016 Apr; 31(4):723-33. PubMed ID: 26874360
[TBL] [Abstract][Full Text] [Related]
13. Effects of Ras homolog gene family, member C gene silencing combined with rapamycin on hepatocellular carcinoma cell growth.
Xie SL; Zhu MG; Chen GF; Wang GY; Lv GY
Mol Med Rep; 2015 Oct; 12(4):5077-85. PubMed ID: 26165487
[TBL] [Abstract][Full Text] [Related]
14. Expression profile of microRNA-200 family in cholangiocarcinoma arising from choledochal cyst.
Chu CH; Chou W; Wang F; Yeh CN; Chen TC; Yeh TS
J Gastroenterol Hepatol; 2016 May; 31(5):1052-9. PubMed ID: 26479153
[TBL] [Abstract][Full Text] [Related]
15. Epithelial-mesenchymal transition in oral squamous cell carcinoma triggered by transforming growth factor-beta1 is Snail family-dependent and correlates with matrix metalloproteinase-2 and -9 expressions.
Qiao B; Johnson NW; Gao J
Int J Oncol; 2010 Sep; 37(3):663-8. PubMed ID: 20664935
[TBL] [Abstract][Full Text] [Related]
16. Antisense RhoC gene suppresses proliferation and invasion capacity of human QBC939 cholangiocarcinoma cells.
Shi Z; Chen ML; He QL; Zeng JH
Hepatobiliary Pancreat Dis Int; 2007 Oct; 6(5):516-20. PubMed ID: 17897917
[TBL] [Abstract][Full Text] [Related]
17. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
[TBL] [Abstract][Full Text] [Related]
18. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
Wang W; Wu F; Fang F; Tao Y; Yang L
Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
[TBL] [Abstract][Full Text] [Related]
20. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
